Summary by Moomoo AI
Fosun Pharma (Group) Co., Ltd. (referred to as 'Fosun Pharma') will hold its 2024 first extraordinary general meeting of shareholders at 1:30 p.m. on September 27, 2024, at the Shanghai Tianxi Jiafu Putike Hotel. The meeting will review and approve, at the discretion of the company, the ordinary resolution to elect Mr. Chen Yuqing as non-executive director and the special resolution to review and approve the amended 'Articles of Association' and its annexes. The shareholders' meeting notice stated that H-shareholders have the right to appoint representatives to attend the meeting and vote, and share transfer registration will be suspended from September 24 to 27, 2024. Fosun Pharma reminds shareholders that related expenses for attending the meeting shall be borne by themselves and it is pointed out that this notice applies only to H-shareholders. Notices to A-shareholders will be issued separately.